- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06501690
Feasibility of a Bedtime Variability Protocol
November 5, 2024 updated by: Emily Hohman, Penn State University
The purpose of this study is to find out if parents and children 6-10 years old are willing and able to follow a protocol to be used to study the effects of short and/or variable sleep in children.
During each of three, one-week long periods, parents will have their child follow one of the following bedtime schedules: 1) habitual bedtime; 2) 1 hour later bedtime; or 3) variable bedtime (+/- 1 hour of habitual bedtime each day).
Children will wear a sleep tracker and parents will complete daily diaries.
Participants will answer questions about their experiences completing the protocol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to find out if parents and children 6-10 years old are willing and able to follow a protocol to be used to study the effects of short and/or variable sleep in children.
Children with medical conditions or taking medications affecting sleep, or children who do not have a regular bedtime, will be excluded.
During each of three, one-week long periods, parents will have their child follow one of the following bedtime schedules: 1) habitual bedtime; 2) 1 hour later bedtime; or 3) variable bedtime (+/- 1 hour of habitual bedtime each day).
Children will wear a sleep tracker and parents will complete daily diaries.
Participants will answer questions about their experiences completing the protocol.
Participants will attend an initial enrollment visit to complete consent and receive instruction on the protocol.
Participants will then complete the three experimental conditions in a randomized, counterbalanced order.
Participants will complete a phone or Zoom check in at the end of the first two conditions, and an in-person or Zoom visit at the end of the third condition where their opinions about the protocol feasibility and acceptability will be assessed, answer any questions, and provide them instruction for the next condition (when applicable).
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Pennsylvania State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Child age 6-10 years
- Parent age 18 years or older
- Child has a regular bedtime (goes to bed within 30 minutes of the same time on 5 or more days per week)
Exclusion Criteria:
- Child has a medical condition impacting sleep (e.g., narcolepsy, sleep apnea)
- Child has a developmental disorder or delay (e.g., autism, Down syndrome)
- Child regularly takes supplements or medications (prescription or over the counter) for sleep, such as melatonin or antihistamines
- Not English speaking
- Not willing to follow bedtime protocol
- Residing in the same household as a current or previous participant (i.e., only 1 child per household may complete study)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Habitual bedtime
For one week, children will follow their habitual bedtime.
|
|
|
Experimental: Late bedtime
For one week, children will go to bed one hour later than their habitual bedtime
|
Participants will go to bed 1 hour later than their habitual bedtime
|
|
Experimental: Variable bedtime
For one week, children will go to bed at a prescribed time that will vary each day within +/- 1 hour of habitual bedtime.
|
Participants will go to bed at a prescribed time that varies each day within +/-1 hour of habitual bedtime
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to bedtime protocol
Time Frame: Daily during each of the 3, one-week intervention periods
|
Parents will report on the time their child went to bed
|
Daily during each of the 3, one-week intervention periods
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parent perception of feasibility of following the protocol (semi-structured interview)
Time Frame: At the end of 3 week study
|
Parents will provide qualitative answers to questions about their perceptions of following the protocol, including but not limited to whether the protocol was easy to follow, disruptive to their life, disruptive to their child's life.
|
At the end of 3 week study
|
|
Sleep duration
Time Frame: Daily during each of the 3, one-week intervention period
|
Child sleep duration during each intervention period, measured by actigraphy
|
Daily during each of the 3, one-week intervention period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 10, 2024
Primary Completion (Actual)
September 30, 2024
Study Completion (Actual)
September 30, 2024
Study Registration Dates
First Submitted
July 2, 2024
First Submitted That Met QC Criteria
July 8, 2024
First Posted (Actual)
July 15, 2024
Study Record Updates
Last Update Posted (Estimated)
November 8, 2024
Last Update Submitted That Met QC Criteria
November 5, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Brigham and Women's HospitalNot yet recruitingObstructive Sleep Apnea | Sleep-disordered BreathingUnited States
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
Clinical Trials on Late bedtime
-
Oregon Health and Science UniversityRecruiting
-
Indiana UniversitySaint-Joseph University; Purdue UniversityCompleted
-
University of ChicagoNational Heart, Lung, and Blood Institute (NHLBI)CompletedSleep | Insulin Resistance | Type 2 Diabetes | Sleep DeprivationUnited States
-
Johns Hopkins UniversityUniversity of Arkansas; National Marrow Donor ProgramCompleted
-
Saint Joseph's University, PhiladelphiaJohnson & Johnson Consumer Inc. (J&JCI); Temple University; Simms/Mann Family... and other collaboratorsCompletedSleep | Sleep Disturbance | Child DevelopmentUnited States
-
National Taiwan UniversityCompleted
-
Emily GusemanCompleted
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedObesity | Cardiovascular Disease | Diabetes Mellitus, Type IIUnited States
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingSleep | Autism | Sleep Disturbances in ChildrenUnited States
-
University of PittsburghRecruitingSleep Disturbance | AutismUnited States